Clinical Form 3: Clinical Medications Worksheets

Generic Name Trade Name Classification Dose Route Time/frequency

Budesonide Pulmicort Antiasthmatics, 0.5 mg=2 mL Inh Q12 hr

corticosteroids
Peak Onset Duration Normal dosage range

1-4 wk Within 24 hr Unknown 1-2 inhalations twice daily up to 4 inhalations per day.

Why is your patient getting this medication For IV meds, compatibility with IV drips and/or solutions

Asthma (maintenance/prophylactic; long-term control) May N/A

decrease the need for systemic corticosteroids and delay lung
damage associated with asthma.
Rate of Administation

N/A

Mechanism of action and indications Nursing Implications (what to focus on)

Contraindications/warnings/interactions
(Why med ordered)
Hypersensitivity, Use cautiously in Diabetes or glaucoma
Potent, locally acting anti-inflammatory and immune modifier.
Therapeutic Effects: Decreased frequency and severity of asthma. Common side effects
Prevention of pulmonary damage from asthma.
Headache, dyspepsia, gastroenteritis, Back pain, flu like syndrome.

Interactions with other patient drugs, OTC or herbal medicines Lab value alterations caused by medicine
(ask patient specifically)
May cause increased serum and urine glucose concentrations if
None for this patient significant absorption occurs.
Be sure to teach the patient the following about this medication

Take medication as directed. Do not discontinue medication without

consulting health care professional. This medication is not for
treatment of an acute asthma attack. Caution to avoid smoking.
Nursing Process- Assessment Assessment Evaluation

(Pre-administration assessment) Why would you hold or not give this med? Check after giving

Monitor respiratory status and lung sounds. PFTs may Hypersensitivity, Alterations in respiratory Management of the symptoms of
be assessed periodically. status. chronic asthma. Prevention of
pulmonary damage that results
from chronic asthma.